Daniel Weeden
Internal Medicine · Rogers, ARNPI 1144288317
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $188 and has fallen 88.6% since, to $21 in 2025.
Across 52 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$138
- Sanofi Pasteur Inc.$59
- AbbVie$55
- AstraZeneca$53
- Boston Scientific$51
- Merck$47
- plus $390 from 17 others
What the payments were for
- Food & beverage$793100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 9 | $138 |
| Sanofi Pasteur Inc. | 4 | $59 |
| AbbVie(2 entities) | 4 | $55 |
| AstraZeneca | 3 | $53 |
| Boston Scientific | 3 | $51 |
| Merck | 3 | $47 |
| Novo Nordisk | 3 | $46 |
| Genentech USA, Inc. | 3 | $42 |
| Idorsia Pharmaceuticals US Inc | 3 | $40 |
| Johnson & Johnson | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Bayer | 1 | $23 |
| Gilead | 1 | $19 |
| Valeritas, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| GSK | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $13 |
| Pfizer | 1 | $11 |
| Ironshore Pharmaceuticals Inc. | 1 | $11 |
How this compares
$793 in reported general payments places this provider in the 70th percentile of 614 internal medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 12 | $176 |
| Atorvastatin Calcium | 14 | $77 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Rogers
- Stuart BensonRogers$24K
- Douglas EddyRogers$9K
- Ruben TejadaRogers$6K
- Kristy JonesRogers$6K
- David PyleJonesboro$93K
- Aaron StrobelLittle Rock$32K
- Purnima SarkarEarle$21K
- John NorwoodJonesboro$21K
- Ahmed AliConway$18K
- Jeremy DavisLittle Rock$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.